Protica Bio
Immunotherapy-based Diagnostics Platform
StartupProtica Bio is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2021. Immunotherapy-based Diagnostics Platform. Protica Bio was founded by Olga Nissan. Key investors include VLX Ventures. The company has 1-10 employees. Core technologies: Platforms & Interfaces, Web, Artificial Intelligence, Machine Learning.
The company follows a B2C business model. Product stage: Customer Development.
- StageSeed
- ProductCustomer Development
- ModelB2C
- Employees1-10
- HQJerusalem
- Last RoundUndisclosed
- VLX VenturesLead
Olga NissanFounder & CEO
What does Protica Bio do?
Protica Bio combines cutting-edge proteomics and machine learning to improve immunotherapy-based clinical decisions and new drug discoveries, with the goal of creating diagnostic capabilities and elevating the response rate for current and future treatments. The company is utilizing a proprietary platform developed by a leading expert in the field of mass spectrometry from the Weizmann Institute. In addition to laboratory research, the company integrates deep proteomics with machine learning to create diagnostic capabilities and elevate the response rate for current and future treatments.
Who founded Protica Bio?
Protica Bio was founded in 2021 by Olga Nissan (Founder & CEO).
What sector is Protica Bio in?
Protica Bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Test Diagnostics & Screening, with core technologies in Platforms & Interfaces, Web, Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories.
Where is Protica Bio located?
Protica Bio is based in Sderot Wolfson 9, Jerusalem, Israel.